Yunfei Chen

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital · ORCID：0000-0001-7309-8545

发表论文 66 篇 · 总被引 573 次 · h-index 9

代表论文

• A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia (2024 · New England Journal of Medicine · 被引 48)
• Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial (2024 · Signal Transduction and Targeted Therapy · 被引 33)
• Daratumumab in Relapsed or Refractory Pediatric Immune Thrombocytopenia (2025 · New England Journal of Medicine · 被引 10)
• Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial (2025 · BMJ · 被引 6)
• Duodenal mucosal ablation with irreversible electroporation reduces liver lipids in rats with non-alcoholic fatty liver disease (2025 · World Journal of Gastroenterology · 被引 5)
• Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohort (2024 · Leukemia · 被引 4)